ENTITY
China Resources Sanjiu Medical & Pharma

China Resources Sanjiu Medical & Pharma (000999 CH)

67
Analysis
Health Care • China
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. manufactures and markets medicines, healthcare products, and medical instruments. Through its subsidiaries, the Company also operates in pharmaceutical trading, printing, food manufacturing, real estate development, and provides medical services.
more
•21 Feb 2015 00:02

Opening of E-commerce Channel to Change China's Drug Market

Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...

Share
•05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
497 Views
Share
•26 Feb 2026 08:55

Pre-IPO Brightgene Bio-Medical Technology (A/H Listing) - 2025 Will Face a Performance Slump

​Declining APIs business, VBP and high R&D costs may impact performance in 2025, but rebound expected in 2026 with potential contributions from...

Logo
253 Views
Share
•02 Jun 2025 09:16

China Healthcare Weekly (Jun.1)-Akeso/Summit's Disappointing Ph3 Readout,Valuation Outlook of Biokin

​CR Sanjiu plans to transfer 49.8967% equity of Sanjiu (Anguo).Summit/Akeso's disappointing phase 3 readout raises doubts on FDA approval for...

Logo
514 Views
Share
•15 Apr 2025 09:48

China Resources Beverage IPO Lockup- Cornerstones Coming Out of Lockup Ahead of the Large PE Release

China Resources Beverage (2460 HK) raised around US$750m in its Hong Kong IPO in October 2024. The lockup on its cornerstone investors is set to...

Logo
537 Views
Share
x